✦ LIBER ✦

28.16 Inhibition of anastomotic intimal hyperplasia by a specific collagen type I inhibitor

✍ Scribed by A.D. Callow; E. Choi; D. Brown; N. Sehgal; U. Ryan

Book ID: 117684650
Publisher: Elsevier Science
Year: 1997
Tongue: English
Weight: 132 KB
Volume: 5
Category: Article
ISSN: 0967-2109
DOI: 10.1016/s0967-2109(97)80156-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Inhibition of type I collagen film degra

Inhibition of type I collagen film degradation by tumour cells using a specific antibody to collagenase and the specific tissue inhibitor of metalloproteinases (TIMP)

✍ GAVRILOVIC, J; REYNOLDS, J; MURPHY, G 📂 Article 📅 1985 🏛 Elsevier Science 🌐 English ⚖ 812 KB

Localized versus systemic angiotensin II

Localized versus systemic angiotensin II receptor inhibition of intimal hyperplasia in experimental vein grafts by the specific angiotensin II receptor inhibitor L158,809

✍ Gregory J. Fulton; Mark G. Davies; Lizzie Barber; Einar Svendsen; Per-Otto Hagen 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 268 KB

Inhibition of intimal hyperplasia after

Inhibition of intimal hyperplasia after vein grafting by in vivo transfer of human senescent cell-derived inhibitor-1 gene

✍ Bai, H; Morishita, R; Kida, I; Yamakawa, T; Zhang, W; Aoki, M; Matsushita, H; No 📂 Article 📅 1998 🏛 Nature Publishing Group 🌐 English ⚖ 577 KB

Type I collagen is a molecular target fo

Type I collagen is a molecular target for inhibition of angiogenesis by endogenous thrombospondin-1

✍ Zhou, L; Isenberg, J S; Cao, Z; Roberts, D D 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 282 KB

Inhibition of systemic sclerosis dermal

Inhibition of systemic sclerosis dermal fibroblast type I collagen production and gene expression by simvastatin

✍ Natalia Louneva; Gonzalo Huaman; Joanna Fertala; Sergio A. Jiménez 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 785 KB

## Abstract ## Objective To examine whether statins are capable of modulating collagen gene expression in cultured systemic sclerosis dermal fibroblasts. ## Methods Cultured dermal fibroblasts from 3 patients with diffuse systemic sclerosis of recent onset were treated with 5 μ__M__ and 10 μ__M_

The structural basis of Janus kinase 2 i

The structural basis of Janus kinase 2 inhibition by a potent and specific pan-Janus kinase inhibitor

✍ Lucet, I. S. 📂 Article 📅 2006 🏛 American Society of Hematology 🌐 English ⚖ 619 KB